Seroprevalence of human T-cell leukemia/lymphoma virus type I and type II (HTLV-I/HTLV-II) infection among volunteer blood donors in Kuwait

Medical Principles and Practice

Volumn 8, Issue 1, 1999, Pages 45-50

  Al Mufti, Siham ^a,b   Voevodin, Alexander ^a   Ahmed, Sabeeha ^a   Hamdan, Samia Al ^a   Al Basheer, Abdul Azis ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

Antibodies; Blood donors; Human T cell leukemia lymphoma virus type I; India; Iran; Kuwait; Western blot

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOBLOTTING; INDIAN; KUWAIT; MALE; SEROPREVALENCE; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0033002382     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026068     Document Type: Article

References (30)

1. Yoshida M, Seiki M, Yamaguchi K, Takasuki K: Monoclonal integration of human T-cell leukemia provirus in all primary tumours of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984;81:2534-2537.
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;ii:407-410.
3. Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
4. Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC, Blattner W, Allain J-P: Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis 1990;162:347-352.
5. Zella D, Mori L, Sala M, Ferrante P, Casoli C, Magnani G, Achilli G, Cattaneo E, Lori F, Bertazzoni U: HTLV-II infection in Italian drug abusers. Lancet 1990;336:575-576.
6. Fukushima Y, Takahashi H, Hall WW, Nakasone T, Nakata S, Song P, Dinh Duc D, Hien B, Nguyen XQ, Ngoc Trinh T, Nishioka K, Kitamura K, Komura K, Vahlue A, Honda M: Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in south Vietnam. AIDS Res Hum Retroviruses 1995;11:637-645.
7. Biglione M, Gessain A, Quiruelas S, Fay O, Taborda MA, Fernandez E, Lupo S, Panzita A, de The G: Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina. J Acquir Immune Defic Syndr 1993;6:631-633.
8. Lairmore MD, Jacobson S, Gracia F, De BK, Castillo L, Larreategui M, Roberts BD, Levine PH, Blattner WA, Kaplan JE: Isolation of human T cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990;87: 8840-8844.
9. Goubau P, Liu HF, De Lange GG, Vandamme AM, Desmyter J: HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res Hum Retroviruses 1993;9:709-713.
10. Gessain A, Mauclere P, Froment A, Biglione M, Le Hesran JY, Tekaia F, Millan J, de The G: Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: An ancient origin for HTLV-II in Africa. Proc Natl Acad Sci USA 1995;92:4041-4045.
11. Levine PH, Jacobson S, Elliott R, Cavallero A, Cololough G, Dorry C, Stephenson C, Knigge RM, Drummond J, Nishimura M, Taylor M, Wiktor S, Shaw G: HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-127.
12. Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S: Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1991;163: 435-440.
13. Harrington WJ Jr, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SK, Snodgrass S, Toedter G, Cabrai L, Poiesz B: Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-414.
14. McFarlin DE: Neurological disorders related to HTLV-I and HTLV-II. J Acquir Immune Defic Syndr 1993;6:640-644.
15. Sheremata WA, Harrington WJ Jr, Bradshaw PA, Foung SK, Raffanti SP, Berger JR, Snodgrass S, Resnick L, Poiesz BJ: Association of 'tropical ataxic neuropathy' with HTLV-II. Virus Res 1993;29:71-77.
16. Pagliuca A, Pawson R, Mufti GJ: HTLV-I screening in Britain. BMJ 1995;311:1313-1314.
17. Hadlock KG, Goh CJ, Bradshaw PA, Perkins S, Lo J, Kaplan JE, Khabbaz R, Foung SK: Delineation of an immunodominant and human T cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 1995;86:1392-1399.
18. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakava S, Miyoshi I: Adult T-cell leukemia: Antigen in ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-6480.
19. Blattner W, Kalyanaraman V, Robert-Guroff M, Lister T, Galton D, Sarin P, Crawford D, Catovsky D, Greaves M, Gallo R: The human C retrovirus HTLV in black from the Caribbean region and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982;30:257-264.
20. de The G, Giordano C, Gessain A, Howlett W, Sonan T, Alkani F, Rosling H, Carton H, Mouanga Y, Caudie C, Stenger F, Malone G: Human retroviruses HTLV-1, HIV-1, HIV-2 and neurological diseases in some equatorial areas of Africa. J AIDS 1989;2:550-556.
21. Meytes D, Schochat B, Lee H, Nadel G, Sidi Y, Cerney M, Swanson P, Shaklai M, Kilim Y, Elgat M, Chin E, Danon Y, Rosenblat J: Serological and molecular survey for HTLV-I infection in a high-risk Middle Eastern group. Lancet 1990;336: 1533-1535.
22. Achiron A, Pinhas-Hamiel O, Doll L, Djaldetti R, Chen A, Ziv I, Avni A, Frankel G, Melamed E, Shohat B: Spastic paraparesis associated with human T-lymphotropic virus type I: A clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Ann Neurol 1993;34:670-675.
23. Safai B, Huang JL, Boeri E, Farid R, Raafat J, Schutzer P, Ahkami R, Franchini G: Prevalence of HTLV type I infection in Iran: A serological and genetic study. AIDS Res Hum Retroviruses 1996;12:1185-1190.
24. Denic S, Nolan P, Doherty J, Garson J, Tuke P, Tedder R: HTLV-I infection in Iraq. Lancet 1990;336: 1135-1136.
25. Voevodin A, Al-Mufti S, Farah S, Khan R, Miura T: Molecular characterization of human T-lymphotropic virus, type 1 (HTLV-1) found in Kuwait: Close similarity with HTLV-1 isolates originating from Mashhad, Iran. AIDS Res Hum Retroviruses 1995;11:1255-1259.
26. Farah S, Khan R, Voevodin A, Al-Mufti S, Rudwan M, Hussein J, Ravindran M: HTLV-1 myelopathy in Kuwait: A report of two patients and review of possible links. Med Principles Pract 1996;5:108-113.
27. Al-Mufti S, Voevodin A, Ahmed S, Al-Hamdan S, Al-Basheer AA: Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:88-90.
28. Voevodin A, Gessain A: Common origin of human T lymphotropic virus type-I from Iran, Kuwait, Israel, and La Réunion Island. J Med Virol 1997;52:77-82.
29. Voevodin A: Substitution T → C 4783 and T → C 6569 in the pol and env genes of HTLV-I are characteristic for the isolates originating in the Middle East. Leukemia 1997; 11(suppl 3):52-53.
30. Brennan M, Runganga J, Barbara JA, Contreras M, Tedder RS, Garson JA, Tuke PW, Mortimer PP, McAlpine L, Tosswill JH: Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ 1993; 307:1235-1239.